Furthermore, the addition of the proteasome inhibitor MG132 resulted in a further increase in the expression of Death Receptor 5 (DR5), thereby sensitizing MM cells to ZD55-TRAIL-induced apoptosis (23). This evidence concerns the gene TNFRSF10B and Miyoshi myopathy.